Rapid quantification of ischaemic injury and cerebroprotection in brain slices using densitometric assessment of 2,3,5-triphenyltetrazolium chloride staining

Journal of Neuroscience Methods

Volumn 102, Issue 1, 2000, Pages 43-51

  Mathews, Kusum S ^a   McLaughlin, Daniel P ^a   Ziabari, Laila H ^a   Toner, Christopher C ^a   Street, Philip C ^a   Hisgrove, Emma ^a   Bezzina, E Lindsey ^a   Stamford, Jonathan A ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

2,3,5 Triphenyltetrazolium chloride; Cerebral cortex; Densitometry; Ischaemia; Striatum

Indexed keywords

DIZOCILPINE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CONCENTRATION (PARAMETERS); CORPUS STRIATUM; DENSITOMETRY; DIAGNOSTIC VALUE; HISTOLOGY; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING;

ANIMAL; BRAIN ISCHEMIA; CEREBRAL CORTEX; DENSITOMETRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DYES; MALE; NEOSTRIATUM; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T; TETRAZOLIUM SALTS; TIME FACTORS; TISSUE CULTURE;

EID: 0034668141     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(00)00277-6     Document Type: Article

References (18)

1. Armstrong-James M., Millar J. Carbon fibre microelectrodes. J. Neurosci. Methods. 1:1979;279-287.
2. Bederson J.B., Pitts L.H., Germano S.M., Nishimura M.C., Davis R.L., Bartkowski H.M. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 17:1986;1304-1308.
3. Bose B., Osterholm J.L., Berry R. A reproducible model of focal cerebral ischemia in the cat. Brain Res. 311:1984;385-391.
4. Bose B., Jones S.C., Lorig R., Friel H.T., Weinstein M., Little J.R. Evolving focal cerebral ischemia in cats: spatial correlation of nuclear magnetic resonance imaging, cerebral blood flow, tetrazolium staining, and histopathology. Stroke. 19:1988;28-37.
5. Clemens J.A., Phebus L.A. Dopamine depletion protects striatal neurons from ischaemia-induced cell death. Life Sci. 42:1988;707-713.
6. Goldlust E.J., Paczynski R.P., He Y.Y., Hsu C.Y., Goldberg M.P. Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains. Stroke. 27(9):1996;1657-1662.
7. Hatfield R.H., Mendelow A.D., Perry R.H., Alvarez S., Modha P. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropath. Appl. Neurobiol. 17:1991;61-67.
8. Lye R.H., Shrewsbury-Gee J., Slater P., Latham A. Rat middle cerebral artery occlusion: use of evoked potentials and tetrazolium staining to assess chronic ischaemia. J. Neurosci. Methods. 22:1987;133-139.
9. Mathews K.S., Ziabari L., Street P.C., Hisgrove E., Toner C.C., McLaughlin D.P., Stamford J.A. Semiquantitative assessment of 'ischaemic' damage in brain slices by tetrazolium red. Br. Neurosci. Assoc. Abstr. 15:1999;122.
10. Park C.K., Mendelow A.D., Graham D.I., McCulloch J., Teasdale G.M. Correlation of triphenyltetrazolium chloride perfusion staining with conventional neurohistology in the detection of early brain ischaemia. Neuropath. Appl. Neurobiol. 14:1988;289-298.
11. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, London.
12. Pulsinelli W.A., Brierley W.A., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischaemia. Ann. Neurol. 11:1982;491-498.
13. Stamford J.A. Fast cyclic voltammetry: monitoring transmitter release in real time. J. Neurosci. Methods. 34:1990;67-72.
14. Toner C.C., Stamford J.A. Real time measurement of DA release in an in vitro model of neostriatal ischaemia. J. Neurosci. Methods. 67:1996;133-140.
15. Toner C.C., Stamford J.A. Involvement of N- and P/Q- but not L- or T-type voltage-gated calcium channels in ischaemia-induced striatal dopamine release in vitro. Brain Res. 748:1997a;85-92.
16. Toner C.C., Stamford J.A. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro. Neurosci. 81:1997b;999-1007.
17. Toner C.C., Stamford J.A. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro. Eur. J. Pharmacol. 340:1997c;133-143.
18. Watson G.B., Lopez O.T., Charles V.D., Lanthorn T.H. Assessment of long-term effects of transient anoxia on metabolic activity of rat hippocampal slices using triphenyltetrazolium chloride. J. Neurosci. Methods. 53:1994;203-208.